Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Scius Pharma Support AB
AB
Active
Org 5569394595
Scheelevägen 2, 223 63
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 12 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Scius Pharma Support AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
615
569
807
990
1 406
Staff expenses
−381
—
—
—
—
EBITDA
93
−265
−294
62
459
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
93
−265
−294
62
459
Net financials
2
3
3
—
—
Profit before tax
95
−261
−291
61
460
Tax
−0
−0
−0
−15
−80
Net profit
95
−261
−291
46
380
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
812
757
1 044
1 587
1 894
Equity
759
664
925
1 496
1 729
Long-term debt
0
0
0
0
0
Short-term debt
54
93
119
91
164
Total debt
54
93
119
91
164
Financial ratios
5-year trend
EBITDA margin
15,1 %
This company
15,8 %
Market median
This company
Market median
4% below market
2021
2025
Equity ratio
93,4 %
This company
38,2 %
Market median
This company
Market median
145% above market
2021
2025
Return on equity
12,5 %
This company
18,4 %
Market median
This company
Market median
32% below market
2021
2025
Net profit margin
15,5 %
This company
8,1 %
Market median
This company
Market median
91% above market
2021
2025
Asset turnover
0,76×
This company
1,12×
Market median
This company
Market median
32% below market
2021
2025
Debt / equity
0,07×
This company
0,62×
Market median
This company
Market median
89% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Scius Pharma Support AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
